hepatocellular carcinoma
Conditions
Interventions
Group 1 (Sequential liver transplantation treatment after conversion therapy to complete clinical response):NA
Group 2 (Sequential liver resection treatment after conversion therapy to complete clinical response):NA
Group 3 (Sequential non-surgical treatment after conversion therapy to complete clinical response):NA
Sponsors
Shulan (Hangzhou) Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Age range: 18-85 years old; (2) Diagnosed as HCC based on imaging methods such as computed tomography (CT) and/or magnetic resonance imaging (MRI), characterized by early enhancement and delayed enhancement attenuation; (3) After conversion therapy, the Child Pugh score for liver function was A; (4) There was no extrahepatic metastasis during diagnosis; (5) Successfully achieving complete clinical response after conversion therapy; (6) Complete clinical case information and data; (7) Long term follow-up after surgery.
Exclusion criteria
Exclusion criteria: (1) Recurrent HCC; (2) Accompanied by a history of other malignant tumors; (3) Patients who have not received conversion therapy; (4) CT images with poor quality or incomplete images; (5) Clinical and follow-up data are incomplete.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival, OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease free survival, DFS;Serum parameter; | — |
Countries
China
Contacts
Public ContactZhe Yang
Shulan (Hangzhou) hospital
Outcome results
None listed